SLC31A1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.83939999998106E-06 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.37330000000458E-05 |
Normal-vs-Stage2 |
4.698300E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.806570E-04 |
Stage1-vs-Stage2 |
7.226600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.765200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.163000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.731199999495E-07 |
Normal-vs-AfricanAmerican |
7.851800E-01 |
Normal-vs-Asian |
2.942900E-03 |
Caucasian-vs-AfricanAmerican |
6.016800E-01 |
Caucasian-vs-Asian |
6.865000E-01 |
AfricanAmerican-vs-Asian |
5.610000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.565700E-04 |
Normal-vs-Female |
1.56502999999475E-05 |
Male-vs-Female |
6.645000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.14179999999953E-05 |
Normal-vs-Extreme_Weight |
9.88579999999795E-05 |
Normal-vs-Obese |
1.249600E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.216200E-01 |
Normal_Weight-vs-Obese |
2.974400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.150800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.718800E-03 |
Normal-vs-Age(41-60Yrs) |
5.952000E-04 |
Normal-vs-Age(61-80Yrs) |
5.49280000372576E-08 |
Normal-vs-Age(81-100Yrs) |
8.346400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.144400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.423000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.731200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.165000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.231200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.590200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.851700E-02 |
Normal-vs-Grade 3 |
4.106800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.187800E-01 |
Grade 2-vs-Grade 4 |
2.851700E-02 |
Grade 3-vs-Grade 4 |
4.106800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.39770000000084E-05 |
Normal-vs-N1 |
1.997080E-04 |
N0-vs-N1 |
6.946800E-01 |
|
|